PubRank

Kiyoshi Kubota

Author PubWeight™ 20.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Transl Res 2007 4.23
2 Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebo-controlled trial to evaluate the antialbuminuric effects of an aldosterone blocker in hypertensive patients with albuminuria. Hypertens Res 2010 1.44
3 Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol 2006 1.33
4 Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan. Jpn J Clin Oncol 2010 0.96
5 The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiol Drug Saf 2013 0.96
6 Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study. Pharmacoepidemiol Drug Saf 2013 0.94
7 The impact in Japan of regulatory action on prescribing of dopamine receptor agonists: analysis of a claims database between 2005 and 2008. Drug Saf 2011 0.91
8 Age, gender, insulin and blood glucose control status alter the risk of ischemic heart disease and stroke among elderly diabetic patients. Cardiovasc Diabetol 2011 0.91
9 Selected control events and reporting odds ratio in signal detection methodology. Pharmacoepidemiol Drug Saf 2010 0.88
10 Metabolic predictors of ischemic heart disease and cerebrovascular attack in elderly diabetic individuals: difference in risk by age. Cardiovasc Diabetol 2013 0.84
11 Incidence of interstitial lung disease in patients with mesothelioma in the west part of Japan. Pharmacoepidemiol Drug Saf 2011 0.82
12 Claims-based definition of death in Japanese claims database: validity and implications. PLoS One 2013 0.80
13 Sample-size formula for case-cohort studies. Epidemiology 2011 0.80
14 Hypertension management in diabetic patients: prescribing trends from 1999 to 2005 in three Japanese university hospitals. Pharmacoepidemiol Drug Saf 2008 0.79
15 Brief Report: Databases in the Asia-Pacific Region: The Potential for a Distributed Network Approach. Epidemiology 2015 0.79
16 Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events. Geriatr Gerontol Int 2013 0.78
17 Ex-drinking may be a surrogate for unmeasured risk factors for upper gastrointestinal bleeding: reappraisal and an additional survey of subjects from a case-control study in Japan. Eur J Epidemiol 2009 0.77
18 Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries. Drug Saf 2015 0.77
19 Comparison of losartan with ACE inhibitors and dihydropyridine calcium channel antagonists: a pilot study of prescription-event monitoring in Japan. Drug Saf 2002 0.77
20 Resolving a double standard for risk management of thalidomide: an evaluation of two different risk management programmes in Japan. Drug Saf 2010 0.75
21 Importance of lipid levels in elderly diabetic individuals: baseline characteristics and 1-year survey of cardiovascular events. Circ J 2008 0.75
22 [What is drug-epidemiology?]. Nihon Naika Gakkai Zasshi 2007 0.75
23 How frequent are invasive therapies required in patients receiving tamsulosin for benign prostatic hyperplasia? A retrospective long-term study. Int J Urol 2006 0.75
24 Calcium channel blockers and myocardial infarction: a case--control study in a Japanese hospital. Pharmacoepidemiol Drug Saf 2002 0.75